GH Research is a privately-held clinical-stage biopharmaceutical company, founded in 2018, developing novel therapies for the management of mental diseases.
In order to obtain approval for our therapies, we are investigating their safety and efficacy in clinical trials as required by the United States Food and Drug Administration, European Medicines Agency, and other regulatory agencies worldwide.GH001 has completed a healthy...
GH Research is a privately-held clinical-stage biopharmaceutical company, founded in 2018, developing novel therapies for the management of mental diseases.
In order to obtain approval for our therapies, we are investigating their safety and efficacy in clinical trials as required by the United States Food and Drug Administration, European Medicines Agency, and other regulatory agencies worldwide.GH001 has completed a healthy volunteer study and is currently being investigated in patients with Treatment-Resistant Depression. We believe our lead product GH001 has the potential to offer ultra-rapid and deep remissions in depression.
Sponsored Ad
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.